This study is testing a new drug called linvoseltamab combined with another drug, dupilumab, for adults with severe food allergies. A food allergy happens when your immune system overreacts to certain foods, producing IgE antibodies (IgE stands for Immunoglobulin E), which can cause allergic reactions. The study aims to check if this combination is safe and how it affects the body.

To join, you must have a severe food allergy and be on dupilumab for some conditions or willing to start it. The study will look at any side effects of the drugs and how they change the levels of different antibodies in the blood. Participants will also need to use an epinephrine auto-injector and may require vaccinations.

• The study requires you to continue dupilumab treatment for its duration.
• Participants must not have certain health conditions, like asthma or infections.
• People who are pregnant or breastfeeding cannot join.

If you think you qualify and are interested, consider discussing with your doctor.